Risk prediction to inform strategies for the primary prevention of cardiovascular disease is universally recommended by clinical practice guidelines in the US and worldwide.1,2 A risk-based prevention paradigm matches the intensity of the prevention effort with the absolute risk of the individual….
This pragmatic nonrandomized multisite clinical trial examines the effectiveness of patient-directed educational materials provided before primary care appointments in promoting deprescribing for low-benefit and high-risk…
This case report describes an HIV-positive patient with bilateral syphilitic panuveitis, for whom diagnosis was initially delayed by negative treponemal testing.
Research has found that in nearly 40% of opioid overdose deaths, documented bystanders could have potentially administered the lifesaving medicine naloxone. But in a promising…
Nature Medicine – Next-generation metagenomic testing increases the accuracy and sensitivity of the etiology of central nervous system infections in hospitalized patients.
This study aims to characterize the individual-level agreement of polygenic risk scores for coronary heart disease that perform similarly at the population level.
Ankeet Bhatt, MD, MBA, discusses a study he led from AHA 2024 examining the cost-effectiveness of dapagliflozin based on how soon therapy was initiated following…
After the fall of “Roe v. Wade,” thousands of out-of-state patients traveled to Maryland for abortion care. The state is trying to diversify who can…
California has detected the country’s first case of a new mpox strain in a person who recently traveled from Eastern Africa
Audio Interview from the New England Journal of Medicine — NEJM at AHA — Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia
